首页> 外文期刊>Molecular Carcinogenesis >Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21Cip1 in colon cancer cells.
【24h】

Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21Cip1 in colon cancer cells.

机译:细胞外信号调节激酶和c-jun N末端激酶途径参与结肠癌细胞中12-O-十四烷酰佛波醇13-乙酸盐诱导的p21Cip1的上调。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Protein kinase C (PKC), a family of serine-threonine kinases, has been implicated in the regulation of colon tumorigenesis. However, the specific isoform of PKC involved in this process is not clear. In the present study, we found that treatment of the cultured human colon cancer cell line COLO-205 with a PKC agonist, 12-O-tetradecanoylphorbol-13-acetate (TPA), resulted in cell-cycle arrest at the G(0)/G(1) phase, decrease in cell number, PKCgamma isoform translocation, and upregulation of p21(Cip1) protein. Pretreatment of the cells with a PKC inhibitor, staurosporine, prevented the TPA-induced upregulation of p21(Cip1) protein. Based on the findings of the present study including that (a) both extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) were activated in the TPA-treated COLO-205 cells, (b) pretreatment with the mitogen-activated protein kinase kinase inhibitor PD98059 but not with the p38 mitogen-activated protein kinase inhibitor SB203580 blocked the TPA-induced p21(Cip1) in COLO-205 cells, and (c) transient transfection of the COLO-205 cells with dominant negative ERK or JNK plasmid significantly suppressed the TPA-induced p21(Cip1) protein induction, we conclude that both the ERK and JNK pathways are involved in the TPA-induced upregulation of p21(Cip1) protein in the COLO-205 cells.
机译:蛋白激酶C(PKC),丝氨酸-苏氨酸激酶家族,已参与结肠肿瘤发生的调控。但是,尚不清楚此过程中涉及的PKC的特定同工型。在本研究中,我们发现用PKC激动剂12-O-十四烷酰phorbol-13-乙酸盐(TPA)处理培养的人结肠癌细胞系COLO-205,会导致细胞周期停滞在G(0) / G(1)期,细胞数量减少,PKCgamma同工型移位,并上调p21(Cip1)蛋白。用PKC抑制剂星形孢菌素预处理细胞可防止TPA诱导的p21(Cip1)蛋白上调。基于本研究的发现,包括(a)在TPA处理的COLO-205细胞中,细胞外信号调节激酶(ERK)和c-jun N末端激酶(JNK)均被激活,(b)用丝裂原激活的蛋白激酶激酶抑制剂PD98059但不与p38丝裂原激活的蛋白激酶抑制剂SB203580阻断TPA诱导的COLO-205细胞中的p21(Cip1),以及(c)瞬时转染具有优势的COLO-205细胞阴性ERK或JNK质粒可显着抑制TPA诱导的p21(Cip1)蛋白诱导,我们得出结论,ERK和JNK途径均参与TPA诱导的COLO-205细胞中p21(Cip1)蛋白的上调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号